Literature DB >> 18698159

Thymidylate synthase and 5-fluorouracil: a cautionary tale.

Fred Bunz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18698159     DOI： 10.4161/cbt.7.7.6414

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  4 in total

1.  Thymidylate synthase expression and p21(WAF1)/p53 phenotype of colon cancers identify patients who may benefit from 5-fluorouracil based therapy.

Authors:  Violetta Sulzyc-Bielicka; Pawel Domagala; Dariusz Bielicki; Krzysztof Safranow; Wenancjusz Domagala
Journal:  Cell Oncol (Dordr)       Date:  2013-11-26       Impact factor: 6.730

2.  E2F1/TS Immunophenotype and Survival of Patients with Colorectal Cancer Treated with 5FU-Based Adjuvant Therapy.

Authors:  Violetta Sulzyc-Bielicka; Pawel Domagala; Dariusz Bielicki; Krzysztof Safranow; Wojciech Rogowski; Wenancjusz Domagala
Journal:  Pathol Oncol Res       Date:  2016-01-29       Impact factor: 3.201

3.  SHP-2 restricts apoptosis induced by chemotherapeutic agents via Parkin-dependent autophagy in cervical cancer.

Authors:  Dewen Yan; Danyang Zhu; Xiumin Zhao; Jun Su
Journal:  Cancer Cell Int       Date:  2018-01-15       Impact factor: 5.722

4.  Sub-Lethal 5-Fluorouracil Dose Challenges Planarian Stem Cells Promoting Transcriptional Profile Changes in the Pluripotent Sigma-Class Neoblasts.

Authors:  Gaetana Gambino; Chiara Ippolito; Monica Evangelista; Alessandra Salvetti; Leonardo Rossi
Journal:  Biomolecules       Date:  2021-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.